PortViewPortView
TriSalus Life Sciences logo

TriSalus Life Sciences (TLSI) Stock Analysis

NASDAQHealthcareMedical - Devices

$5.22+0.97%
1-year price historyRange $2.52 – $7.50
52-week range$5.22
$2.20$7.95

What TriSalus Life Sciences does

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.

Key metrics

Market cap
$321.42M
P/E (TTM)
-3.11
EPS (TTM)
$-1.68
Beta
0.43
Dividend yield
0.00%
Revenue / share
$0.77
50-day avg
$4.69
200-day avg
$4.83
52-week high
$7.95
52-week low
$2.20
CEO
Mary T. Szela

ETFs linked to TLSI

Broad-market and Healthcare sector ETFs an investor holding TriSalus Life Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TLSI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TLSI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for TriSalus Life Sciences?
TriSalus Life Sciences trades under the ticker TLSI on NASDAQ.
Which exchange is TLSI listed on?
TLSI is listed on NASDAQ.
What sector does TriSalus Life Sciences operate in?
TriSalus Life Sciences is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze TLSI in a portfolio?
PortView shows TLSI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.